Biotech
3 stories in this blend
The Neuron·6d agoModerna and Merck report successful trial for AI-designed cancer therapy
Moderna used artificial intelligence to analyze genetic data from patient tumors and identify targets that best provoke an immune response. When combined with an existing drug, the personalized mRNA vaccine significantly reduced melanoma recurrence during a major clinical trial.
The Neuron·6d agoPersonalized mRNA skin cancer therapy achieves success in late-stage clinical trial
Pharmaceutical companies Merck and Moderna announced positive Phase 3 trial results for an individualized melanoma treatment designed with artificial intelligence. Algorithms examine each patient's blood and tumor mutations to target specific proteins, creating a tailored vaccine administered alongside standard immunotherapy.
The Neuron·Aug 18Singapore test-runs data server using living brain cells
Researchers in Singapore launched a prototype data system powered by lab-grown human brain cells instead of conventional computing chips. The living tissue runs basic computational workloads while consuming only a small fraction of standard server power.
